Suomija – Vakcinos – Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028)

Suomija – Vakcinos – Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028)

I dalis: Perkančioji organizacija

I.1) Pavadinimas ir adresai:

Oficialus pavadinimas: Ministry of Social Affairs and Health
Adresas: P.O. BOX 33
Miestas: Helsinki
Pašto kodas: 00023
Šalis: Suomija
Asmuo ryšiams:
El-paštas: tuija.orre@thl.fi
Interneto adresas (-ai):
Pagrindinis adresas: https://stm.fi/en/frontpage

II dalis: Objektas

II.1.1) Pavadinimas:

Pneumococcal Conjugate (PCV) Vaccine for children and risk groups 2025-2026 and (2026-2027, 2027-2028)
Nuorodos numeris: THL/4896/2.02.06/2023

II.1.2) Pagrindinis BVPŽ kodas:

33651600 Farmacijos produktai ;

II.1.3) Sutarties tipas:

Kita

II.1.4) Trumpas aprašymas:

The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) request your tender for Pneumococcal Conjugate Vaccine for children and risk groups belonging to the National Vaccination Programme in Finland. The contract period is two years 2025 - 2026. The procurement contains two contract period renewals (1+1) to extend the contract for the periods 2026 - 2027 and 2027-2028. The procurement contains additional procurement option for maximum 50.000 doses but it does not create any obligation by the Customer to purchase any additional vaccine doses from Supplier. THL will supply a written notification for contract period renewals and additional procurement option with the following terms: - THL shall supply a written notification six (6) months before the end of the previous contract period. THL announces the more precise delivery plan of the contract period renewal in the written notification. The price quoted in the tender shall be applied to the Contract period renewals (2026-2027 and 2027-2028) too, however, the Supplier´s proposal for a change of price will be handled as described in Annex 1 Contract. - THL shall supply a written notification for the additional procurement option at least six (6) months before the estimated delivery date. Notwithstanding the foregoing the Supplier shall use its best reasonable efforts to supply number of ordered doses of the Article as soon as possible. The delivery plan shall be agreed mutually. The price quoted in the contract period shall be applied to this additional procurement option. Additional procurement option can be utilized once if needed during contract period or in either of two contract period renewals. The additional procurement option can be less than maximum 50 000 doses in one delivery. The decision about the ordered quantity is in sole discretion of THL. For the sake of clarity, the minimum quantity of doses ordered through the Contract in case of no Contract period renewals or option is exercised is 268.800 doses. Estimated quantity for the contract period including the contract period renewals is 660.000 doses +/- 20 %. THL reserves an option to order maximum 50.000 additional doses as described in section "Description of renewals and options". Total quantity for the contract period including the contract period renewals (1+1) and option is at most 842.000 doses. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the Call for tender refer to local time in Finland. Call for Tenders, annexes: Annex 1 Contract Annex 2 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 3 Description of the Handi Service

II.2) Aprašymas:

II.2.1) Kitas (-i) šio pirkimo BVPŽ kodas (-ai):

33651600 Vakcinos
33600000 Farmacijos produktai